Healthy Extracts (HYEX) Convertible Debt (2017 - 2025)

Healthy Extracts (HYEX) reported Convertible Debt of $247423.0 for Q2 2025, down 56.34% quarter-over-quarter from $566712.0 in Q3 2024.

Healthy Extracts (HYEX) Convertible Debt (2017 - 2025) Analysis & Trends

Healthy Extracts has reported Convertible Debt for 9 years, with the latest figure at $247423.0 in Q2 2025.

  • For the quarter ending Q2 2025, Convertible Debt changed N/A year-over-year to $247423.0; the trailing twelve-month figure through Jun 2025 stood at $247423.0 (changed N/A YoY), and the FY2023 full-year result was $530860.0, down 10.88% from the prior year.
  • Convertible Debt for Q2 2025 stood at $247423.0, down from $566712.0 in the prior quarter.
  • The five-year high for Convertible Debt was $864750.0 in Q3 2021, with the low at $6750.0 in Q1 2022.
  • Historically, Convertible Debt has averaged $454518.7 across 5 years, with a median of $519098.5 in 2022.
  • Annual changes were most pronounced in 2021 — Convertible Debt surged 12711.11% — and 2022, when it plunged 98.05%.
  • Healthy Extracts' Convertible Debt stood at $171750.0 in 2021, then soared by 246.81% to $595638.0 in 2022, then slipped by 10.88% to $530860.0 in 2023, then rose by 6.75% to $566712.0 in 2024, then slumped by 56.34% to $247423.0 in 2025.
  • The last three Convertible Debt figures came in at $247423.0 (Q2 2025), $566712.0 (Q3 2024), and $530860.0 (Q4 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn
10 Healthy Extracts - - 957,429.00

Historic Data

Download Data
DateValue
Jun 30, 2025 247,423.00
Sep 30, 2024 566,712.00
Dec 31, 2023 530,860.00
Sep 30, 2023 595,638.00
Jun 30, 2023 626,516.00
Mar 31, 2023 595,638.00
Dec 31, 2022 595,638.00
Sep 30, 2022 360,750.00
Jun 30, 2022 507,337.00
Mar 31, 2022 6,750.00
Dec 31, 2021 171,750.00
Sep 30, 2021 864,750.00
Jun 30, 2021 346,750.00
Mar 31, 2021 346,750.00
Dec 31, 2020 6,750.00
Sep 30, 2020 6,750.00
Jun 30, 2020 166,750.00
Mar 31, 2020 166,750.00
Dec 31, 2019 166,750.00
Sep 30, 2019 166,750.00